Find uplifting stories about heroes, innovations, and solutions
8 results for "kras"
A breakthrough drug from Revolution Medicines is giving real hope to pancreatic cancer patients for the first time in decades. The pill, called daraxonrasib, successfully targeted KRAS, a protein scientists once thought was impossible to drug.
A breakthrough drug called daraxonrasib is giving hope to pancreatic cancer patients after scientists spent nearly 50 years trying to target the KRAS mutation. Patients like 36-year-old Leanna Stokes are living far longer than expected thanks to this medical breakthrough.
University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2F6e%2F57%2F6e57732e-0e31-405f-b3c9-349c613b16e2%2Fkrasner_combat_1965.jpg)
For decades, Lee Krasner was known mainly as Jackson Pollock's wife, even though she was the more accomplished artist when they met. Now the Met Museum is finally presenting them as equals in a groundbreaking exhibition.
Northwestern University researchers developed a breakthrough therapy that grabs "undruggable" cancer proteins and drags them to the cell's trash system for destruction. The approach worked against MYC and KRAS, two proteins that drive many aggressive cancers and resist most treatments.
After decades of slow progress, breakthrough drugs targeting a genetic mutation found in 90% of pancreatic cancers are nearing FDA approval in 2026. The KRAS inhibitors now in late-stage trials could transform treatment for one of medicine's deadliest diseases.
A new triple therapy treatment completely eliminated pancreatic tumors in mice, offering hope for one of the deadliest cancers. The breakthrough could transform treatment for the 67,000 Americans diagnosed each year.
Researchers in Spain have found a triple-drug combination that eliminates pancreatic tumors in mice without them returning. The breakthrough could eventually transform treatment for one of cancer's deadliest forms.